1887
Rapid communication Open Access
Like 0
This item has no PDF Download

Abstract

We assessed the impact of COVID-19 on diagnostic services for tuberculosis (TB) by national reference laboratories in the WHO European Region. Of 35 laboratories, 30 reported declines in TB sample numbers, amounting up to > 50% of the pre-COVID-19 volumes. Sixteen reported reagent or consumable shortages. Nineteen reallocated ressources to SARS-CoV-2 testing, resulting in an overall increase in workload, largely without a concomitant increase in personnel (n = 14). This poses a risk to meeting the 2025 milestones of the End TB Strategy.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.24.2100426
2021-06-17
2025-04-01
/content/10.2807/1560-7917.ES.2021.26.24.2100426
Loading
The full text of this article is not currently available.

References

  1. Nikolayevskyy V, Holicka Y, van Soolingen D, van der Werf MJ, Ködmön C, Surkova E, et al. , ERLTB-Net-2 study participants. Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe. Eur Respir J. 2021;57(1):2003890.  https://doi.org/10.1183/13993003.03890-2020  PMID: 33184119 
  2. Simões D, Stengaard AR, Combs L, Raben D, EuroTEST COVID-19 impact assessment consortium of partners. Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Euro Surveill. 2020;25(47):25.  https://doi.org/10.2807/1560-7917.ES.2020.25.47.2001943  PMID: 33243354 
  3. World Health Organization (WHO). WHO Global Tuberulosis Report 2020. Geneva: WHO; 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
  4. World Health Organization (WHO). Information Note Tuberculosis and COVID-19. Geneva: WHO. [Accessed: 25 Mar 2021]. Available from: https://www.who.int/news/item/15-12-2020-updated-who-information-note-ensuring-continuity-of-tb-services-during-the-covid-19-pandemic
  5. World Health Organization Regional Office for Europe. Rapid communication on the role of the GeneXpert® platform for rapid molecular testing for SARS-CoV-2 in the WHO European Region. Copenhagen: WHO Regional Office for Europe. [Accessed: 25 Mar 2021]. Available from: https://www.euro.who.int/en/health-topics/communicable-diseases/tuberculosis/publications/2020/rapid-communication-on-the-role-of-the-genexpert-platform-for-rapid-molecular-testing-for-sars-cov-2-in-the-who-european-region-2020-produced-by-whoeurope
  6. Stop TB. Partnership. Considerations for selection of SARS-CoV-2 diagnostics and potential multiplexing : A perspective to ensure continuity of care for people with TB. Geneva: Stop TB Partnership; 14 May 2020. Available from: http://www.stoptb.org/assets/documents/covid/Considerations for selection of SARS-CoV-2 diagnostics.pdf
  7. Homolka S, Paulowski L, Andres S, Hillemann D, Jou R, Günther G, et al. Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding. Emerg Infect Dis. 2020;26(11):2549-54.  https://doi.org/10.3201/eid2611.202602  PMID: 32956612 
  8. World Health Organization Regional Office for Europe. Final report on implementation of the Tuberculosis Action Plan for the WHO European Region 2016–2020. Copenhagen:WHO Regional Office for Europe; 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/337926/9789289055307-eng.pdf
  9. Glaziou P. Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020. medRxiv. 4 May 2020.  https://doi.org/10.1101/2020.04.28.20079582 
  10. Cilloni L, Fu H, Vesga JF, Dowdy D, Pretorius C, Ahmedov S, et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine. 2020;28:100603. PMID: 33134905 
  11. Stop TB. Partnership. One year on, new data show global impact of Covid-19 on TB epidemic is worse than expected. Geneva: Stop TB Partnership; 18 Mar 2021. Press release. Available from: http://www.stoptb.org/webadmin/cms/docs/Release%20for%20COVID%20and%20TB%202021%20report%20draft_16%20March_FINAL.pdf
  12. World Health Organization (WHO). Impact of the COVID-19 pandemic on TB detection and mortality in 2020. Geneva: WHO; 22 Mar 2021. Available from: https://www.who.int/publications/m/item/impact-of-the-covid-19-pandemic-on-tb-detection-and-mortality-in-2020
  13. Migliori GB, Thong PM, Akkerman O, Alffenaar JW, Álvarez-Navascués F, Assao-Neino MM, et al. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020. Emerg Infect Dis. 2020;26(11):2709-12.  https://doi.org/10.3201/eid2611.203163  PMID: 32917293 
  14. Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, et al. Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy. Eur Respir J. 2020;56(4):2002665.  https://doi.org/10.1183/13993003.02665-2020  PMID: 32703780 
  15. Fei H, Yinyin X, Hui C, Ni W, Xin D, Wei C, et al. The impact of the COVID-19 epidemic on tuberculosis control in China. Lancet Regional Health - West Pacific 2020;3:100032. http://dx.doi.org/ https://doi.org/10.1016/j.lanwpc.2020.100032 
  16. Graciaa DS, Kempker RR, Sanikidze E, Tukvadze S, Mikiashvili L, Aspindzelashvili R, et al. TB research amidst the COVID-19 pandemic. Int J Tuberc Lung Dis. 2021;25(3):167-70.  https://doi.org/10.5588/ijtld.20.0830  PMID: 33688804 
  17. McQuaid CF, McCreesh N, Read JM, Sumner T, Houben RMGJ, White RG, et al. , CMMID COVID-19 Working Group. The potential impact of COVID-19-related disruption on tuberculosis burden. Eur Respir J. 2020;56(2):2001718.  https://doi.org/10.1183/13993003.01718-2020  PMID: 32513784 
  18. World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard. Geneva: WHO. [Accessed: 25 Mar 2021]. Available from: https://covid19.who.int/
/content/10.2807/1560-7917.ES.2021.26.24.2100426
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error